Metformin May Alter the Metabolic Reprogramming in Cancer Cells by Disrupting the L-Arginine Metabolism: A Preliminary Computational Study

Metabolic reprogramming in cancer is considered to be one of the most important hallmarks to drive proliferation, angiogenesis, and invasion. AMP-activated protein kinase activation is one of the established mechanisms for metformin’s anti-cancer actions. However, it has been suggested that metformi...

Descripción completa

Detalles Bibliográficos
Autores principales: Espinosa-Rodriguez, Bryan Alejandro, Treviño-Almaguer, Daniela, Carranza-Rosales, Pilar, Ramirez-Cabrera, Monica Azucena, Ramirez-Estrada, Karla, Arredondo-Espinoza, Eder Ubaldo, Mendez-Lopez, Luis Fernando, Balderas-Renteria, Isaias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049129/
https://www.ncbi.nlm.nih.gov/pubmed/36982390
http://dx.doi.org/10.3390/ijms24065316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049129/
https://www.ncbi.nlm.nih.gov/pubmed/36982390
http://dx.doi.org/10.3390/ijms24065316

Ejemplares similares